U.S. Markets close in 1 hr 31 mins
  • S&P 500

    3,858.40
    +6.55 (+0.17%)
     
  • Dow 30

    31,228.22
    +39.84 (+0.13%)
     
  • Nasdaq

    13,539.07
    +81.82 (+0.61%)
     
  • Russell 2000

    2,147.90
    -12.72 (-0.59%)
     
  • Crude Oil

    53.18
    -0.13 (-0.24%)
     
  • Gold

    1,869.10
    +2.60 (+0.14%)
     
  • Silver

    26.00
    +0.23 (+0.89%)
     
  • EUR/USD

    1.2161
    +0.0046 (+0.3770%)
     
  • 10-Yr Bond

    1.1040
    +0.0140 (+1.28%)
     
  • Vix

    21.26
    -0.32 (-1.48%)
     
  • GBP/USD

    1.3723
    +0.0068 (+0.4995%)
     
  • USD/JPY

    103.5000
    -0.0700 (-0.0676%)
     
  • BTC-USD

    32,382.14
    -2,569.54 (-7.35%)
     
  • CMC Crypto 200

    642.44
    -37.46 (-5.51%)
     
  • FTSE 100

    6,715.42
    -24.97 (-0.37%)
     
  • Nikkei 225

    28,756.86
    +233.60 (+0.82%)
     

Company News for Jan 12, 2021

Zacks Equity Research
·1 min read
  • Shares of Mesoblast Limited MESO jumped 31.6% after the company announced that its rexlemestrocel-L reduced heart attacks, strokes and cardiac deaths.

  • The ODP Corporation’s ODP shares rose 19.4% after USR Parent, Inc. proposed to acquire the company for $40 per share in cash.

  • Shares of Eli Lilly and Company LLY surged 11.7% after the company announced that its Alzheimer's treatment slowed the decline of patients' ability to think by 32% in a phase 2 trial.

  • AZZ Inc.’s AZZ shares rose 0.6% after the company reported third quarter of fiscal 2021 earnings of $0.80 per share, beating the Zacks Consensus Estimate of $0.58.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Eli Lilly and Company (LLY) : Free Stock Analysis Report
 
AZZ Inc. (AZZ) : Free Stock Analysis Report
 
The ODP Corporation (ODP) : Free Stock Analysis Report
 
Mesoblast Limited (MESO) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research